Previous Article | Next Article ![]()
Journal of Bacteriology, May 2002, p. 2411-2419, Vol. 184, No. 9
0021-9193/02/$04.00+0 DOI: 10.1128/JB.184.9.2411-2419.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Dieter Knowle, and Robert M. Blumenthal*
Department of Microbiology & Immunology and Program in Bioinformatics & Proteomics/Genomics, Medical College of Ohio, Toledo, Ohio 43614-5806
Received 14 December 2001/ Accepted 4 February 2002
|
|
|---|
|
|
|---|
RM system ubiquity is consistent with the selectable phenotypes just summarized, but these phenotypes only help to explain why the systems are maintained once they have entered a given bacterium. It is less clear how these systems move throughout the microbial biosphere. To this end, it would be useful to track the movement of a given RM system by finding very closely related systems in different bacterial host genera. In a truly orthologous RM system pair, all genes in each system would have an ortholog in the other system, the systems would have the same specificity, and the relative gene positions would be conserved. Restriction endonucleases exhibit extreme structural and sequence diversity and are often unrelated to one another even in systems having related methyltransferases and regulatory proteins. For example, a recent BLAST alignment of the corresponding proteins from the PvuII and BamHI RM systems yielded expect scores of 7 x 10-15 for the methyltransferases and 4 x 10-9 for the regulatory C proteins (described below), but 5,156 for the endonucleases. One of the rare exceptions to this generalization is provided by the EcoRI and RsrI systems, from Escherichia coli and Rhodopseudomonas sphaeroides, respectively, which both cleave the sequence G
AATTC at the indicated position. Their endonucleases are very closely related (50% identity), but their methyltransferases are not (30, 64, 65).
Within a given genus, there are many examples of fully orthologous RM systems in different species; we provide another such example in this report. However, there are very few known examples of such orthologous RM systems in two or more distinct host genera. One such rare case involves NgoPII from the eubacterium Neisseria gonorrhoeae and MthTI from the archaeon Methanobacterium thermoformicicum (48, 66). A second such example is provided by EcoHK31I from E. coli and EaeI from Enterobacter agglomerans (36).
We report here on a pair of orthologous RM systems from distinct genera, one of which is the PvuII system. The PvuII RM system is produced by a strain of the enteric gram-negative organism Proteus vulgaris and cleaves the sequence CAG
CTG as shown (21). Its methyltransferase acts on the internal cytosine in that sequence (10), generating N4-methylcytosine (13). The regulation of this system has been studied and involves an autogenous regulatory protein with unusual properties, called CPvuII (1, 68, 69, 73). PvuII is also the first RM system for which X-ray crystallography yielded structures for both the endonuclease and the methyltransferase (5, 16, 22). The methyltransferase, MPvuII, is particularly interesting, because it is circularly permuted relative to the majority of AdoMet-dependent methyltransferases (19, 28, 39).
As described below, a search of the unfinished microbial genome database revealed an apparent RM system in Salmonella enterica Paratyphi A that is very closely related to the PvuII system. Although Proteus and Salmonella both belong to the family Enterobacteriaceae and show some evidence of past horizontal exchanges (52), they are well separated within that family, so the discovery of closely related RM systems (including closely related endonucleases) was unexpected.
We report here completion of the sequence characterization of the PvuII plasmid pPvu1, the isolation and characterization of the genes for the SptAI RM system, and sequence analysis of the genes for the previously identified SbaI RM system. We determine the basis for the inactivity of the SptAI RM system and discuss the fact that these systems are all adjacent to genes associated with genetic mobility.
|
|
|---|
(mrr-hsdRMS-mcrBC)
80 lacZ
M15
lacX74 deoR recA1 ara
139
(ara-leu)7697 galU galK rpsL (Strr), endA1 nupG. mcrBC+ host strains would have been killed by producing methyltransferases such as MPvuII (10, 53, 55, 67). The plasmids used were based on the vectors pCRII-TOPO (InVitrogen), pKK232-8 (Pharmacia), and pACYC184 (15). Strains of Salmonella or Proteus were obtained from the American Type Culture Collection, and the strain numbers are given in each case. Cloning the SptAI and SbaI RM systems. We obtained S. enterica serovar Paratyphi A chromosomal DNA from American Type Culture Collection (Manassas, Va.; ATCC strain 9150) and used PCR to amplify the SptAI system. The oligonucleotide primers that were used matched the released S. enterica serovar Paratyphi A genome sequence: 5'-ATTAATGGTCCAATGGTGGGC and 5'-CCCGCTATTTTTAACGAAATAAGCC. The PCR product was ligated to pCRII-TOPO and introduced by transformation into E. coli strain TOP10. An insert-containing clone was fully sequenced with vector-specific primers.
Restriction and modification assays.
To test for in vitro activities of restriction endonucleases or modification methyltransferases, appropriate E. coli strains were grown overnight in Luria-Bertani (LB) medium, 1.5 ml was pelleted by centrifugation for 10 min at 15,000 x g, and the pellets were washed in the appropriate activity buffer. The pellets were resuspended in 5 ml of the same buffer for both restriction endonuclease methyltransferase assays: 10 mM Tris-HCl (pH 7.9), 50 mM NaCl, 1 mM dithiothreitol, and 100 µg of bovine serum albumin per ml. Cells were then opened by sonication in six 1-min pulses at maximal output with a Heat Systems-Ultrasonics model W185 sonifier with the cup horn probe. Cell debris was removed by centrifugation for 10 min at 15,000 x g. For digestion assays, various amounts of cell extract were incubated for 15 min at 37°C with 1 µg of bacteriophage
DNA. Commercial PvuII endonuclease (5 U; New England Biolabs) was used as a positive control for endonuclease assays or to challenge modified DNAs in some protection assays. Digests were resolved on 1% agarose-Tris-borate-EDTA (TBE) gels and stained with ethidium bromide.
To test for in vivo activities of restriction endonucleases or modification methyltransferases, bacteriophage
vir was grown on appropriate E. coli strains. Typically, 5 ml of an overnight E. coli culture grown in MMLB (LB medium containing 10 mM MgSO4 and 0.2% [wt/vol] D-maltose) was pelleted and resuspended to an A600 of 0.5 in 10 mM MgSO4. The suspended cells were infected with
106 PFU of
vir. This mixture was incubated for 15 min at 37°C and then mixed with 2.5 ml of MMLB containing 0.8% agar and poured onto a fresh MMLB plate. After 6 h of growth at 37°C, the plates were overlaid with 5 ml of cold "
Dil" (10 mM Tris-HCl [pH 7.5], 10 mM MgSO4) and incubated overnight at 4°C. Cell debris was pelleted from the pooled liquid, and the supernatant was stored with a few drops of CHCl3 at 4°C. After spot titering 10-µl portions of a dilution series to obtain approximate numbers of PFU per milliliter, triplicate plates were set up at phage concentrations chosen to give 50 to 500 plaques per plate. A fresh overnight culture (0.1 ml) of the appropriate E. coli strain was incubated with the appropriate amount of
vir for 15 min at 37°C and then spread onto MMLB plates. Plaques were counted after overnight incubation at 37°C.
CAT assays. Assays for chloramphenicol acetyltransferase (CAT) activity used the Quan-T-CAT kit (Amersham-Pharmacia), following the manufacturer's instructions. Briefly, 225-µl samples are taken when the LB-grown culture reaches an A600 of 0.3, 0.4, and 0.5. Cells in these samples are pelleted, resuspended in 180 µl of 0.1 M Tris-HCl (pH 7.9), and are then disrupted by six freeze-thaw cycles with dry ice-ethanol and a 37°C bath. Disruption is followed by 10 min at 65°C to inactivate a deacetylating enzyme; CAT itself is stable in response to this treatment, which we confirmed by using purified CAT enzyme. After removal of cell debris by centrifugation (10 min at 15,000 x g), the extract is assayed for CAT activity and for protein content. Protein measurements used the Micro BCA kit (Pierce), with bovine serum albumin as the standard. The assay measures transfer of [3H]acetyl groups from [3H]acetyl-coenzyme A (CoA) (2 to 10 Ci/mmol, 0.5 µCi/assay) to biotinylated deoxychloramphenicol. The deoxychloramphenicol is then separated from unused acetyl-CoA by adherence to streptavidin-linked polystyrene beads, and incorporation is determined by liquid scintillation counting. Each measurement thus uses three independent extracts from the same culture.
Nucleotide sequence determination.
All nucleotide sequence determinations used the BigDye Terminator Cycle Sequencing Ready Reaction kit (ABI, Foster City, Calif.), following the manufacturer's instructions. Reaction products were resolved and characterized on an ABI Prism model 310 Genetic Analyzer. Oligonucleotide primers were typically
20 nucleotides long and were obtained from GenoSys-Sigma (The Woodlands, Tex.).
Nucleotide sequence accession number. The GenBank accession number for the complete SptAI sequence is AF306456.
|
|
|---|
The lower two maps in Fig. 1 show that the bidirectional genetic organization of the PvuII and SptAI systems is conserved, with the methyltransferase gene diverging from the genes for the regulator and endonuclease (which are cotranscribed in the PvuII system) (73). Figure 2 compares the amino acid sequences of the corresponding open reading frames (ORFs) from these two systems. Ignoring the C-terminal gaps due to differing protein lengths, the two methyltransferases show 76% identity, while the two regulatory C proteins are identical at 60% of positions. Most striking is the high similarity between the endonuclease genes (58% identity with gaps only at the termini; 69% identity for the region between the gaps).
![]() View larger version (23K): [in a new window] |
FIG. 1. Comparison of the regions flanking three RM systems. The PvuII, SptAI, and EcoO109I systems are shown (gray ORFs), together with the flanking regions. The PvuII and SptAI systems are oriented so that their homologous genes are aligned, while the EcoO109I system is oriented so that the flanking bacteriophage P4-related genes are in the same orientation as those flanking the SptAI system.
|
![]() View larger version (80K): [in a new window] |
FIG. 2. Comparison of the SptAI and PvuII RM systems. Alignments of corresponding ORFs were generated by BLAST (2). The expect scores are the base 2 logarithms of the ratio of the number of matching residues to the total number of residues in the database (47); accordingly, these scores will change with the size of the database. A vertical line indicates identity; a colon indicates a conservative substitution. Regions of particular significance are shaded. For the C proteins, shading indicates the recognition helix of the predicted helix-turn-helix motif (69); for the methyltransferases, shading indicates the most highly-conserved of the nine sequence motifs (39); and for the endonucleases, shading indicates the amino acids involved in coordinating the Mg2+ ion required for catalysis (26). The endonuclease alignment also shows both the long -helix (cylinder) that forms the subunit interface and the hydrogen bonding (dotted line) between the side chain hydroxyl of Tyr19 and the backbone carbonyl of Gly37 (in RPvuII).
|
The PvuII and SptAI RM systems thus appear to be fully orthologous, suggesting that comparison of their genetic contexts would be informative with respect to the genetic mobility of an RM system. Before proceeding to such analysis, it remained to determine whether the SptAI system is active and, if so, whether it has the same specificity as the PvuII system.
Activities of the SptAI system.
We tested the activity of the SptAI clones in several ways, beginning by showing that the methyltransferase (MSptAI) is active. First, we found that the purified plasmid clone DNA was itself resistant to PvuII digestion in vitro due to self-modification (protection of the pCRII-TOPO vector's four PvuII sites in vivo by its own insert-specified methyltransferase [data not shown]). Second, in the presence of AdoMet, extracts from cells carrying SptAI clones (but not from vector-bearing control strains) protected bacteriophage
DNA from subsequent digestion with PvuII endonuclease (RPvuII [data not shown]). Third, bacteriophage
vir grown on cells containing SptAI clones (but not those grown on vector-bearing control cells) plated with high efficiency on cells producing the PvuII RM system (Table 1). Together, these three results indicate that the SptAI RM system modifies DNA in such a way as to protect CAGCTG sequences from digestion by RPvuII.
|
View this table: [in a new window] |
TABLE 1. In vivo modification of bacteriophage by the SptAI RM system
|
In contrast to the methyltransferase, there is no obvious activity corresponding to the SptAI restriction endonuclease (RSptAI). This is based on the lack of apparent cleavage activity when extracts of cells containing the cloned SptAI system were incubated with bacteriophage
DNA, and the lack of apparent restriction when unmodified
vir was plated onto E. coli cells containing the cloned SptAI system (Table 1). In both cases, E. coli cells producing the cloned PvuII system were used as positive controls and behaved as expected.
Functionality of the SptAI control system. There are several possible explanations for the lack of RSptAI activity. The three most likely are that the sptAICR promoter region is inactive, that the regulator CSptAI is inactive, or that the endonuclease itself is inactive. In the PvuII RM system, CPvuII is absolutely required for transcription of the gene for RPvuIIthe C protein binds to conserved sequences called C-boxes (59) that overlap the promoter for a bicistronic sptAICR transcript, and the complex appears to activate transcription over 20-fold (73).
In comparing the sptAICR promoter regions of the PvuII and SptAI systems, the SptAI C-boxes have two alterations relative to PvuII and three changes relative to the consensus. Specifically, the downstream occurrence of the tandem GACTnAnAGTC consensus (8, 73) is changed to GATCtAtTGTC; this generates a substrate site for the Dam DNA methyltransferase (7, 41), although it is not yet known if Dam methylation has any effect on SptAI expression. The apparent -10 promoter hexamer of the sptAICR promoter is conserved relative to PvuII, but the -35 hexamer and putative UP element of PvuII are substantially altered in SptAI. If either the promoter or the C-boxes are impaired, then the autogenous activation circuit would fail, and transcription of both sptAIC and sptAIR would be poor.
To test the activity of the sptAICR promoter region, we supplied CPvuII from a second plasmid. The C proteins from organisms as different as Proteus vulgaris and Bacillus amyloliquefaciens cross-complement (27), so a possible defect in CSptAI should be complemented by the closely related CPvuII protein, while a defect in the sptAICR promoter or C-boxes (or in RSptAI itself) would not. We saw no sign of SptAI restriction, even in the presence of CPvuII (Table 2). However, we found that the defect is not in the sptAICR promoter. We subcloned this promoter region (from -139 to +149 relative to the predicted start of transcription) into plasmid pKK232-8, placing it upstream of a promoterless CAT (cat) gene. This plasmid, in E. coli strain TOP10, yielded a very large increase in CAT activity when CPvuII was provided from a second, compatible plasmid: there were 3.2 ± 1.0 U of CAT activity per µg of protein in cells carrying a mutant pvuIIC and 1,446 ± 198 U/µg in cells carrying wild-type pvuIIC (average ± standard error [see Materials and Methods for assay]). This indicates that the sptAICR promoter can be activated in trans by the C protein from the PvuII RM system.
|
View this table: [in a new window] |
TABLE 2. Effects of CPvuII on restriction by the SptAI RM system
|
Inactivity of RSptAI.
Another possible explanation for the lack of RSptAI activity is a defect in that protein itself. The most pronounced difference between RSptAI and RPvuII is the 27-amino-acid carboxyl-terminal tail present on the former (Fig. 2). Interestingly, this tail may be the result of a single base change (underlined)at the position of the TAA termination codon of RPvuII, RSptAI has a TCA serine codon and continues until reaching two consecutive TAA codons. The RSptAI tail is highly acidic, with an aspartate and seven glutamates, but no basic amino acids, and this might interfere with binding the negatively charged DNA substrate. To test the possibility that the C-terminal tail has abolished RSptAI activity, we repeated the PCR amplification of the entire system, but this time used a primer that eliminates the tail by changing the TCA
TAA as referred to above. When this truncated system was introduced into E. coli TOP10 cells, we still saw no RSptAI activity, either by restriction of
vir or by digestion of
DNA in cell extracts (data not shown).
Aside from the nonconserved termini, the PvuII and SptAI endonucleases differ at 47 of 155 positions, although some of these are conservative changes. All 47 of these differences occur in both our PCR-amplified clone and in the original genomic DNA sequence, so they do not result from amplification errors. To implicate the change(s) responsible for RSptAI inactivity, we sought to compare the amino acid sequences of RSptAI and RSbaI. SbaI is an active RM system discovered in Salmonella enterica serovar Bareilly that has the same specificity as the PvuII system (40). It seemed likely that the SbaI system would be closely related to the SptAI system and could reveal which changes between RSptAI and RPvuII are irrelevant to activity. We obtained S. enterica serovar Bareilly from the laboratory in which the SbaI system had been discovered, isolated chromosomal DNA, and used SptAI-specific PCR primers to attempt an amplification. We obtained a product of the expected size, cloned it, and determined its nucleotide sequence.
Working with S. enterica serovar Paratyphi A and S. enterica serovar Bareilly DNA in the same laboratory and given the risks of sample cross-contamination, we wished to demonstrate that we hadn't inadvertently amplified the SptAI system. We feel confident that our SbaI clone is authentic for two reasons. First, the nucleotide sequence differs from that of SptAI at seven positions (between the divergent methyltransferase and endonuclease stop codons). Second, and more convincing, the SbaI clone produces an active endonuclease, as indicated by in vitro digestion of bacteriophage
DNA with whole-cell extracts of the E. coli strain. The cleavage pattern generated by RSbaI is indistinguishable from that generated by RPvuII (Fig. 3).
![]() View larger version (81K): [in a new window] |
FIG. 3. Activity of RSbaI. To test for activity of the SbaI endonuclease, E. coli TOP10 with and without the cloned SbaI RM system was grown overnight in LB medium, pelleted, and opened by sonication as described in Materials and Methods. Various amounts of centrifugally cleared cell extract were incubated for 15 min at 37°C with 0.5 µg of bacteriophage DNA. PvuII endonuclease (5 U; New England Biolabs) was used in one lane to provide the expected digestion pattern. Digests were resolved on 1% agarose-TBE gels and stained with ethidium bromide.
|
Sequences flanking the RM systems. Having demonstrated that the complete PvuII and SptAI/SbaI systems were orthologous, we next examined their flanking sequences in an attempt to understand the history of and basis for their movement between bacterial genera. The chromosomally located SptAI genes lie between two ORFs that are closely related to the integrase and polarity-suppression protein (Int and Psu, respectively) of bacteriophage P4. P4 is a defective lysogenic bacteriophage, dependent on a helper bacteriophage for most capsid components (37). The SbaI system lies between the same two genes as the SptAI system.
The PvuII genes are carried on a 4,677-bp low-copy-number plasmid named pPvu1 (10). Roughly two-thirds of this plasmid had been sequenced previously in this laboratory (14, 68, 70) (GenBank accession no. M77223). We have now completed the sequence determination for pPvu1 (GenBank accession no. AF305615); this is the first complete plasmid native to the genus Proteus, based on a search of the NCBI Entrez Genomes bacterial plasmid database (www.ncbi.nlm.nih.gov/PMGifs/Genomes/eub_p.html). We had previously noted an apparent substrate site for the XerCD recombinase (20, 23, 25), beginning just 17 bp from the termination codon of the RPvuII gene, within a small ORF of unknown function named pvuIIO (Fig. 1), and this site may confer recombinational mobility on the PvuII system (14).
In addition, the previously uncharacterized region of pPvu1 contains a mob operon, which should increase intercellular movement of this plasmid by allowing it to use the transfer machinery of other, conjugative plasmids. The mob operon comprises four genes, mobA to -D, with the usual arrangement of mobC preceding mobA, followed by mobB and mobD, with alternative reading frames within mobA (49, 61, 62). This characteristic gene arrangement strengthens the individual gene assignments based on sequence comparison, although the mob operon is not yet proven to be functional.
Since pPvu1 contains a mob operon, we also looked to see if the PvuII genes were present in Proteus vulgaris isolates other than the one in which it was originally found (ATCC 13315) (21). To this end, we made opposing primers that matched, respectively, the pvuIIM and pvuIIR genes and which generate an
1-kbp band following PCR amplification when DNA from ATCC 13315 is used. We obtained no positive results for any of the strains tested: ATCC 6380, 6897, 8427, 33420, and 49132all P. vulgarisand ATCC 7002 (Proteus mirabilis) and 33519 (Proteus penneri).
|
|
|---|
However, the worst possible outcome for phage defense, on a whole-population level, would be variation leading to a Mod+ Res- phenotype, as seen with SptAI, because the efficient production of modified bacteriophage on such cells would undermine the effectiveness of the restriction endonuclease in any Res+ cells in the population. Furthermore, whatever selfish behavior may be exhibited by an RM system is lost in a Mod+ Res- cell, so neither phage defense nor selfishness explains the persistence of such systems. Nonetheless, in a study of Helicobacter pylori, several such examples were found (33). It is unclear why Mod+ Res- phenotypes appear to be so common.
In the case of SptAI, the Res- phenotype is due to a defect in the endonuclease, probably a single T
C transition leading to a Tyr19
His substitution in the subunit dimerization interface (Fig. 2, bottom). The altered nucleotide sequence shows no obvious features one would expect to see in a region designed to be highly polymorphic or to phase vary (43). It is not clear why the Tyr19
His substitution would abolish activity. In the structure for RPvuII (e.g., 1EYU.pdb), Tyr19 points away from the interface, and its hydroxyl forms a hydrogen bond to the backbone carbonyl of Gly37 on the same chain (Fig. 4). Substitution of His at that position would abolish the bond to Gly37, and this might make the subunit interface more flexible. The observation that coexpression of RSptAI and RPvuII leads to no apparent diminution of RPvuII activity indicates that the RSptAI mutation is not dominant negative, consistent with (though not proving) a defect in subunit dimerization.
![]() View larger version (37K): [in a new window] |
FIG. 4. Role of Tyr19 in RPvuII. On the left is the polypeptide backbone of RPvuII (from PDB 1EYU; rendered by Chime software, MDL, Inc.). The DNA helical axis is perpendicular to the page. The two subunits of this homodimeric protein are in different shades. The subunit interface is generated by proline-kinked -helices at the amino termini (top, in orientation shown). The Tyr19 side chain is indicated by the circle on each subunit. The dotted line indicates the hydrogen bond between the Tyr19 hydroxyl and the backbone carbonyl of Gly37; the oxygen-oxygen distance is 2.7 Å. In RSptAI, which is inactive, this Tyr has been replaced by His (Fig. 2).
|
Mobility of type II RM systems. There appears to be an association between the genes for RM systems and genes that increase genetic mobility. The simplest explanation is that the original association of RM and mobility genes is a random occurrence, with those RM systems that happen to associate with mobility loci being overrepresented in samplings of extant systems purely as a consequence of the increased mobility. There may be some additional effect resulting from the fact that restriction endonuclease-mediated cleavage can itself stimulate recombination (4, 42), although it's not yet clear that the genes for RM systems change their immediate genetic contexts more readily than other genes.
Carriage of restriction genes by defective prophages appears to be fairly common. For example, the McrA methylation-dependent restriction enzyme is specified by the defective
14 prophage in many strains of E. coli (56). However it is particularly striking that another type II RM system has been found in an exactly analogous position to the SptAI and SbaI genesas illustrated in Fig. 1, the EcoO109I system is carried between the P4 Int and Psu genes in a strain of E. coli (31). Aside from their analogous locations, the SptAI and EcoO109I genes are not closely related. The orthologous systems EcoHK31I from E. coli and EaeI from Enterobacter agglomerans are also adjacent to P4 Int-like ORFs, but there is no Psu ortholog present (36). This phenomenon of a common location for disparate RM systems is similar to one seen in Haemophilus, not known to involve defective prophages, where unrelated systems are found inserted next to the gene for valyl-tRNA synthetase (34).
Only one isolate of P. vulgaris tested contained a PvuII RM system. We made no systematic survey of Salmonella isolates, but two species (S. enterica serovar Paratyphi A and S. enterica serovar Bareilly) contain PvuII-like systems, while no evidence for such systems was found by BLAST analysis of the genome sequences (incomplete, January 2002) of four other Salmonella species: S. enterica subsp. enterica serovar Dublin, S. enterica serovar Enteritidis, S. enterica serovar Typhi, and S. enterica serovar Typhimurium LT2.
Based on activity assay, there is a PvuII-type system in the gram-positive sporulating organism Bacillus alvei (BavI) (REBASE, 1992 posting date [http://rebase.neb.com/cgi-bin/refget?1523]); however, repeated attempts to isolate this system via PCR with a variety of SptAI-specific primers were unproductive (data not shown). It would be interesting to know if the BavI system failed to amplify due to numerous synonymous or conservative changes, or if instead it represents an unrelated system that gained the PvuII specificity via convergent evolution.
Nevertheless, the results presented here show that essentially identical RM systems can appear in completely distinct genetic contexts (comparing the PvuII and SptAI/SbaI systems) and that completely unrelated RM systems can appear in virtually identical genetic contexts (comparing the SptAI/SbaI and EcoO109I systems). These isolated snapshots of RM systems cannot support the detailed analysis needed to understand RM system mobility, although they lay important foundations. A broader and more systematic isolation and context characterization of conspecific RM systems is needed to understand the distribution of these gatekeepers of microbial gene exchange.
We thank the Genome Sequencing Center, Washington University, St. Louis, for communication of DNA sequence data prior to publication and K. Mise (National Institute of Hygeinic Sciences, Tokyo, Japan) for S. enterica serovar Bareilly.
This research was supported by the U.S. National Science Foundation under grant MCB-9904523.
Present address: Department of Biological Sciences, University of WisconsinMilwaukee, Milwaukee, WI 53201. ![]()
|
|
|---|
gene and identification of its product. J. Virol. 71:4502-4508.[Abstract]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»